Truist Securities Maintains Buy on Merck & Co, Raises Price Target to $122
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst Robyn Karnauskas maintains a 'Buy' rating on Merck & Co (NYSE:MRK) and raises the price target from $116 to $122.
August 04, 2023 | 11:43 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities maintains a 'Buy' rating on Merck & Co and raises the price target from $116 to $122, indicating positive sentiment towards the stock.
The raised price target by Truist Securities indicates a positive outlook for Merck & Co. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100